Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax RateTax RateWages, Salaries and Other
Others
Ratios

Apyx Medical (APYX) Shares Outstanding (Weighted Average) (2016 - 2026)

Apyx Medical filings provide 16 years of Shares Outstanding (Weighted Average) readings, the most recent being $41.1 million for Q4 2025.

  • On a quarterly basis, Shares Outstanding (Weighted Average) rose 15.62% to $41.1 million in Q4 2025 year-over-year; TTM through Dec 2025 was $41.1 million, a 15.62% increase, with the full-year FY2025 number at $41.1 million, up 15.62% from a year prior.
  • Shares Outstanding (Weighted Average) hit $41.1 million in Q4 2025 for Apyx Medical, up from $40.7 million in the prior quarter.
  • In the past five years, Shares Outstanding (Weighted Average) ranged from a high of $41.1 million in Q4 2025 to a low of $34.3 million in Q1 2021.
  • Median Shares Outstanding (Weighted Average) over the past 5 years was $34.6 million (2023), compared with a mean of $35.8 million.
  • Biggest five-year swings in Shares Outstanding (Weighted Average): rose 0.01% in 2024 and later rose 17.58% in 2025.
  • Apyx Medical's Shares Outstanding (Weighted Average) stood at $34.3 million in 2021, then grew by 0.54% to $34.5 million in 2022, then increased by 0.31% to $34.6 million in 2023, then grew by 2.66% to $35.5 million in 2024, then rose by 15.62% to $41.1 million in 2025.
  • The last three reported values for Shares Outstanding (Weighted Average) were $41.1 million (Q4 2025), $40.7 million (Q3 2025), and $40.7 million (Q2 2025) per Business Quant data.